Dr. Marcel M Favetta, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 549 Fair St, Bloomsburg, PA 17815 Phone: 570-387-2122 Fax: 570-271-5841 |
Felicia Helene Hawkins, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 425 E 1st St, Bloomsburg, PA 17815 Phone: 570-387-2474 Fax: 570-387-2397 |
Myron Levine, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 425 E 1st St, Suite101, Bloomsburg, PA 17815 Phone: 570-387-2474 |
Dr. Robert Leslie Lozo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6850 Lows Road, Bloomsburg, PA 17815 Phone: 570-416-0437 Fax: 570-416-0517 |
Julie Messimer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 425 E 1st St, Bloomsburg, PA 17815 Phone: 570-387-2474 Fax: 570-387-2397 |
Dr. Michael Kenneth Kowalski, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6850 Lows Road, Bloomsburg, PA 17815 Phone: 570-784-7300 Fax: 570-784-7331 |
News Archive
The recall notice was issued Tuesday by the U.S. Department of Agriculture and affects about 10,260 pounds of frozen spaghetti and meatballs. Food maker Nestle, in its statement, says the affected packages were produced in October. The health risk associated with this recall is low, the USDA's Food Safety and Inspection Service explained. If the product is consumed, there is only a remote probability of adverse health consequences.
A group of researchers from Universidad Carlos III de Madrid has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brain.
Sub-Saharan Africa is in the midst of a rapidly expanding diabetes epidemic that could have devastating health and economic consequences for the region unless quick and decisive action is taken to turn the tide, according to a major new report from a Lancet commission co-led by Harvard T.H. Chan School of Public Health.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the European Medicines Agency (EMA) granted orphan product designation for SBC-102 (Recombinant Human Lysosomal Acid Lipase), the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase (LAL) Deficiency.
A $7 million grant from the National Institutes of Health (NIH) will help researchers at Nationwide Children's Hospital translate new scientific findings and technological developments into novel treatments for the muscular dystrophies. The grant designates Nationwide Children's Hospital as a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, one of three national award recipients in 2010.
› Verified 7 days ago